These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 26882076)

  • 21. Chronic omeprazole use in the elderly is associated with decreased risk of dementia and cognitive decline.
    Weiss A; Gingold-Belfer R; Boltin D; Beloosesky Y; Koren-Morag N; Meyerovitch J; Sharon E; Schmilovitz-Weiss H
    Dig Liver Dis; 2022 May; 54(5):622-628. PubMed ID: 34949554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Proton Pump Inhibitor Use and Risk of Asthma in Children.
    Wang YH; Wintzell V; Ludvigsson JF; Svanström H; Pasternak B
    JAMA Pediatr; 2021 Apr; 175(4):394-403. PubMed ID: 33555324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study.
    Gray SL; Walker RL; Dublin S; Yu O; Aiello Bowles EJ; Anderson ML; Crane PK; Larson EB
    J Am Geriatr Soc; 2018 Feb; 66(2):247-253. PubMed ID: 29134629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
    Luk CP; Parsons R; Lee YP; Hughes JD
    Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review.
    Batchelor R; Gilmartin JF; Kemp W; Hopper I; Liew D
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1426-1435. PubMed ID: 28128476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
    Giuliano C; Wilhelm SM; Kale-Pradhan PB
    Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
    Clark DW; Strandell J
    Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton pump inhibitors do not increase the risk of dementia: a systematic review and meta-analysis of prospective studies.
    Desai M; Nutalapati V; Srinivasan S; Fathallah J; Dasari C; Chandrasekhar VT; Mohammad B; Kohli D; Vaezi M; Katz PO; Sharma P
    Dis Esophagus; 2020 Oct; 33(10):. PubMed ID: 32476013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
    Kwok CS; Jeevanantham V; Dawn B; Loke YK
    Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Janus-like Association between Proton Pump Inhibitors and Dementia.
    Papazoglou A; Arshaad MI; Henseler C; Daubner J; Broich K; Haenisch B; Weiergräber M
    Curr Alzheimer Res; 2021; 18(6):453-469. PubMed ID: 34587884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Proton Pump Inhibitors Usage with Risk of Pneumonia in Dementia Patients.
    Ho SW; Teng YH; Yang SF; Yeh HW; Wang YH; Chou MC; Yeh CB
    J Am Geriatr Soc; 2017 Jul; 65(7):1441-1447. PubMed ID: 28321840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does Long-Term Proton Pump Inhibitor Use Increase Risk of Dementia? Not Really! Results of the Group-Based Trajectory Analysis.
    Huang ST; Tseng LY; Chen LK; Peng LN; Hsiao FY
    Clin Pharmacol Ther; 2019 Sep; 106(3):616-622. PubMed ID: 30861103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No association between proton pump inhibitor use and risk of dementia: Evidence from a meta-analysis.
    Hussain S; Singh A; Zameer S; Jamali MC; Baxi H; Rahman SO; Alam M; Altamish M; Singh AK; Anil D; Hussain MS; Ahmad A; Najmi AK
    J Gastroenterol Hepatol; 2020 Jan; 35(1):19-28. PubMed ID: 31334885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
    Tai SY; Chien CY; Wu DC; Lin KD; Ho BL; Chang YH; Chang YP
    PLoS One; 2017; 12(2):e0171006. PubMed ID: 28199356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton pump inhibitor use and risk of dementia: Systematic review and meta-analysis.
    Li M; Luo Z; Yu S; Tang Z
    Medicine (Baltimore); 2019 Feb; 98(7):e14422. PubMed ID: 30762748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motoric Cognitive Risk and Incident Dementia in Older Adults.
    Chung J; Byun S
    JAMA Netw Open; 2023 Oct; 6(10):e2338534. PubMed ID: 37856120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton-Pump Inhibitors and Risk of Dementia.
    Ford RL; Swanson KA
    Consult Pharm; 2017 Nov; 32(11):682-686. PubMed ID: 29113635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.
    Mahabaleshwarkar RK; Yang Y; Datar MV; Bentley JP; Strum MW; Banahan BF; Null KD
    Curr Med Res Opin; 2013 Apr; 29(4):315-23. PubMed ID: 23362935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study.
    Wang WT; Li CY; Chang YT; Bai YM; Tsai SJ; Chen TJ; Chiou SH; Chen MH
    Allergy Asthma Proc; 2023 Sep; 44(5):345-353. PubMed ID: 37641222
    [No Abstract]   [Full Text] [Related]  

  • 40. Proton pump inhibitor use does not increase dementia and Alzheimer's disease risk: An updated meta-analysis of published studies involving 642305 patients.
    Song YQ; Li Y; Zhang SL; Gao J; Feng SY
    PLoS One; 2019; 14(7):e0219213. PubMed ID: 31265473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.